期刊文献+

尿吡啶酚和脱氧吡啶酚在恶性肿瘤骨转移中的临床意义

Clinical significance of urinary pyridinium cross-links in neoplastic bone disease
下载PDF
导出
摘要 目的 评价尿吡啶酚和脱氧吡啶酚对恶性肿瘤骨转移患者的临床意义。方法 采用ELISA方法检测了 2 6例局限性恶性肿瘤、3 5例进展期肿瘤骨转移阴性和 3 4例骨转移阳性的尿吡啶酚和脱氧吡啶酚水平。结果 进展期肿瘤尿吡啶酚和脱氧吡啶酚水平明显高于限局性肿瘤 (P <0 .0 5 ) ;进展期肿瘤骨转移阳性尿吡啶酚和脱氧吡啶酚水平又明显高于骨转移阴性 (P <0 .0 5 )。结论 尿吡啶酚和脱氧吡啶酚在评价进展期肿瘤骨转移和骨吸收中发挥作用。 ? Objective To evaluate the clinical significance of pyridinoline(PYD) and deoxypyridinoline (DPD) in patients with cancer.Methods Urinary pyridinoline and deoxypyridinoline were measured by ELISA assay in 26 patients with local cancer and 69 advanced cancer patients with or without bone metastases.Results Advanced cancer patiets with or without bone metastases had significantly higher urinary concentrations of PYD and DPD than those of local cancer patients.The concentrations of both cross links were also significantly higher in advanced cancer patients with bone metastases than those without bone metastases.Conclusions These findings suggest that the measurement of PYD and DPD in urine may be useful in assessing bone metastases and bone resorption in cancer patients. 〔
出处 《中国肿瘤临床与康复》 2000年第2期71-72,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 吡啶酚 脱氧吡啶酚 骨转移 pyridinoline deoxypyridinoline bone metastases
  • 相关文献

参考文献10

  • 11,Seyedin SM,RosenDM.Matrix proteins of the skeleton.Curr Opin Cell Bio,1990;2:914-919
  • 22,Berfolini DR,Nedwin GE,Bringman TS,et al.Stimulation of bone resorption and inhibitionof bone formation in vitro by human tumor necrosis factors.Nature,1986;319-516-8
  • 33,RiggsBLOverviewofosteoporosis.WestJMed,1991;154-63-77
  • 44,Delmas PD.Biochemical markers of bone turnover.J Bone Miner Res.1993;8:549-555
  • 55,Seibel Mj,Robins SP and Bilezikian JP.Urinary pyridinium crosslinks ofcollagen:Specific markers of bone resorption in metabolic bone disease.Trends EndocrinolMetab,1992;3:263-270
  • 66,Bettica P,Moro L,Robins SP,et al.Bone-resorption markers galactosylhydroxylysine,pyridinium crosslinks,and hydroxyproline compared.ClinChem,1992;38:2313-2318
  • 77,Gabniel N,Hortobagyi.Option for treatment of metastatic breast cancer.1999 ASCOEducation Book
  • 8陈健,刘淑俊,刘华,宛风玲.多发性骨髓瘤的骨损伤与白细胞介素1研究[J].中华血液学杂志,1994,15(11):571-573. 被引量:3
  • 9陈健 刘淑俊 刘华.白细胞介素素6与多发性骨髓瘤的发病机理的研究[J].国外医学:肿瘤学分册,1995,22:247-249.
  • 1010,Launence M,Demers,Luis Costa,et al.Biochemical markers of bone turnover in patientswith metastatic bone disease.Clin Chem,1995;41(10)1489-1494

二级参考文献1

  • 1赵志辉,中国免疫学杂志,1990年,6卷,98页

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部